Is Upatinib/Refu a hormonal drug? What are its ingredients?

Upadacitinib ( Upadacitinib) is not a hormonal drug in the traditional sense. It is a small molecule oral targeted drug that belongs to the Janus kinase (JAK) inhibitor family. Unlike glucocorticoid drugs (such as prednisone and dexamethasone), upadatinib does not directly interfere with hormone levels in the body, but exerts an anti-inflammatory effect by precisely blocking specific inflammatory signaling pathways. Its design concept is derived from in-depth research on cell signal transduction pathways, especially the key mechanism of the JAK-STAT pathway in autoimmune diseases. Upatinib can selectively inhibit JAK1 subtypes, thereby reducing overactive immune responses and inflammatory responses and effectively controlling disease progression.

From the perspective of pharmaceutical ingredients, the active ingredient of upadacitinib isUpadacitinib (chemical name: [(3S,4R)-3-ethynyl-4-(1-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyrazin-4-yl)-1-pyrrolidinyl] (3-Fluoro-4-methylphenyl)carboxamide) is a compound with stable structure and high oral bioavailability. The drug is marketed as tablets or oral solutions with good absorption and pharmacokinetic characteristics. By inhibiting JAK1 signal transduction, it can block the activity of various cytokines (such as IL-6, IL-12, IFN-γ, etc.), thereby effectively reducing inflammatory damage in joints, intestines, skin and other parts of the body.

Compared with traditional hormone drugs, the biggest advantage of upadatinib is “targeted regulation” rather than “broad-spectrum inhibition”. Hormone drugs often reduce inflammation quickly by suppressing the entire immune system, but long-term use can lead to problems such as osteoporosis, metabolic disorders, and increased risk of infection. By precisely intervening on specific signaling pathways, upadatinib significantly reduces the common systemic side effects of hormonal drugs while maintaining its anti-inflammatory effect. Therefore, it is often regarded as a new immune regulation method in hormone replacement or hormone reduction therapy.

Reference materials:https://www.rinvoq.com/